Kelly Fitzgerald

Title: Innovations in Cancer Treatment by Kelly Fitzgerald

Introduction

Kelly Fitzgerald is an accomplished inventor based in Upton, MA, who has made significant contributions to the field of cancer treatment. With a total of five patents to her name, she is recognized for her innovative approaches to combating cancer, particularly prostate cancer.

Latest Patents

Fitzgerald's latest patents include the development of synthetic antibody mimetic compounds (SYAMS) that specifically target cancer cells. These compounds are designed to function as antibody mimetics, featuring bifunctional and multifunctional properties. They contain at least one cancer cell binding moiety that selectively binds to prostate-specific membrane antigen (PSMA) and an Fc receptor binding moiety that modulates an Fc immune receptor, preferably the FcγRI receptor. The unique design of these compounds allows them to bind selectively to cancer cells that upregulate PSMA, thereby enhancing the immune response against cancer cells. This innovative approach aims to regulate immune responses in patients, leading to improved cancer therapy outcomes.

Career Highlights

Fitzgerald's career is marked by her dedication to research and innovation in cancer treatment. She has been instrumental in developing methods that utilize her patented compounds to treat cancer and reduce the likelihood of metastasis. Her work has the potential to significantly impact the lives of patients battling cancer.

Collaborations

Throughout her career, Fitzgerald has collaborated with notable colleagues, including David Spiegel and Patrick McEnaney. These partnerships have furthered her research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Kelly Fitzgerald's innovative work in developing synthetic antibody mimetic compounds represents a significant advancement in cancer treatment. Her contributions to the field highlight the importance of research and collaboration in the fight against cancer.